Status:
SUSPENDED
External Diaphragm Pacing Therapy and Correlation Analysis of Trunk Balance and Respiratory Function in Stroke Patients
Lead Sponsor:
Zhang liqiong
Conditions:
Stroke
Respiratory Function
Eligibility:
All Genders
35-75 years
Phase:
NA
Brief Summary
The goal of this study is to observe the enhancement of trunk balance ability, pulmonary function, and diaphragm function in stroke patients after treatment of external diaphragm pacing（EDP）, and anal...
Detailed Description
Objective：To observe the enhancement of trunk balance ability, pulmonary function, and diaphragm function in stroke patients after treatment of external diaphragm pacing（EDP）, and analyze the potentia...
Eligibility Criteria
Inclusion
- Patients who meet the diagnostic criteria for stroke for the first time;
- Patients whose disease duration is within 6 months, have received specialist and standardized treatment, and have stable vital signs;
- Patients are informed of this study, voluntarily accept rehabilitation treatment, and sign an informed consent form;
- Patients who have no chronic breathing before and after stroke History of systemic and circulatory diseases.
- The patient can maintain the starting posture evaluated by the mTIS scale for 10 seconds. The standard for the starting posture is: sitting on the edge of the bed without any support for the back and arms, with the thighs in full contact with the bed surface, and with the feet flat and the same width as the hips. On the ground, bend your knees 90° and place your arms on your thighs .
Exclusion
- Those who are complicated by severe heart, lung and other organ dysfunction diseases, such as pulmonary embolism, pacemaker placement, etc.;
- Those who are complicated by severe cognitive impairment and abnormal hearing and understanding;
- There are other reasons why electrical stimulation treatment is not suitable, Such as sudden unstable vital signs, malignant tumors, combined with mental illness, etc.
Key Trial Info
Start Date :
February 13 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06198946
Start Date
February 13 2023
End Date
September 30 2024
Last Update
January 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhangliqiong
Hefei, Anhui, China, 230032